The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

QY Research Reports

SynopsisEDARBI® (azilsartan medoxomil) is a prescription medicine called an angiotensin II receptor blocker (ARB) used to treat high blood pressure (hypertension) in adults. Your doctor may prescribe other medicines for you to take along with EDARBI to treat your high.....

No Of Pages : 93
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisA scavenger system is a medical device used in hospitals. It is used to gather gas or aerosolized medication after it is exhaled from the patient or left the area of the patient. Often used to collect anesthesia, it can also be used to collect any type of gas .....

No Of Pages : 96
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisLabetalol is a medication used to treat high blood pressure and in long term management of angina. This includes essential hypertension, hypertensive emergencies, and hypertension of pregnancy. In essential hypertension it is generally less preferred than a nu.....

No Of Pages : 120
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisLevocarnitine is constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias The global Levocarnitine market was valued at US$ XX million in 2019.....

No Of Pages : 123
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisAlfentanil is a potent but short-acting synthetic opioid analgesic drug, used for anaesthesia in surgery. It is an analogue of fentanyl with around 1/4 to 1/10 the potency of fentanyl and around 1/3 of the duration of action, but with an onset of effects 4x fa.....

No Of Pages : 123
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisAmifampridine (pyridine-3,4-diamine, 3,4-diaminopyridine, 3,4-DAP) is used as a drug, predominantly in the treatment of a number of rare muscle diseases. The free base form of the drug has been used to treat congenital myasthenic syndromes and Lambert–Eaton my.....

No Of Pages : 121
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisFrovatriptan is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation. Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head The global Fro.....

No Of Pages : 121
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisFurazolidone is a nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone binds bacterial DNA which leads to the gradual inhibition of monoamine oxidase The global Furazolidone market was valued at US$ XX million in 2019 .....

No Of Pages : 95
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisDiphenylpyraline (DPP) is a first-generation antihistamine with anticholinergic effects of the diphenylpiperidine class. It is marketed in Europe for the treatment of allergies. DPP has also been found to act as a dopamine reuptake inhibitor and produces hyper.....

No Of Pages : 98
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisNortriptyline is a medication used to treat depression, neuropathic pain, attention deficit hyperactivity disorder (ADHD), stopping smoking and anxiety The global Nortriptyline market was valued at US$ XX million in 2019 and is expected to reach U.....

No Of Pages : 119
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00